332 related articles for article (PubMed ID: 28840297)
21. Cancer stem cell targeting: the next generation of cancer therapy and molecular imaging.
Shigdar S; Lin J; Li Y; Yang CJ; Wei M; Zhus Y; Liu H; Duan W
Ther Deliv; 2012 Feb; 3(2):227-44. PubMed ID: 22834199
[TBL] [Abstract][Full Text] [Related]
22. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
23. Unlocking the potential of anti-CD33 therapy in adult and childhood acute myeloid leukemia.
Laing AA; Harrison CJ; Gibson BES; Keeshan K
Exp Hematol; 2017 Oct; 54():40-50. PubMed ID: 28668350
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
Shan NL; Shin Y; Yang G; Furmanski P; Suh N
Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
[TBL] [Abstract][Full Text] [Related]
25. Cancer stem cells targeting agents--a review.
Shi AM; Tao ZQ; Li H; Wang YQ; Zhao J
Eur Rev Med Pharmacol Sci; 2015 Nov; 19(21):4064-7. PubMed ID: 26592827
[TBL] [Abstract][Full Text] [Related]
26. Cancer stem cell-targeted therapeutics and delivery strategies.
Ahmad G; Amiji MM
Expert Opin Drug Deliv; 2017 Aug; 14(8):997-1008. PubMed ID: 27866420
[TBL] [Abstract][Full Text] [Related]
27. Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance.
Mihanfar A; Aghazadeh Attari J; Mohebbi I; Majidinia M; Kaviani M; Yousefi M; Yousefi B
J Cell Physiol; 2019 Apr; 234(4):3238-3253. PubMed ID: 30317560
[TBL] [Abstract][Full Text] [Related]
28. Targeting Cancer Stemness in the Clinic: From Hype to Hope.
Saygin C; Matei D; Majeti R; Reizes O; Lathia JD
Cell Stem Cell; 2019 Jan; 24(1):25-40. PubMed ID: 30595497
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Potential, Challenges and Future Perspective of Cancer Stem Cells in Translational Oncology: A Critical Review.
Shukla G; Khera HK; Srivastava AK; Khare P; Patidar R; Saxena R
Curr Stem Cell Res Ther; 2017; 12(3):207-224. PubMed ID: 27804866
[TBL] [Abstract][Full Text] [Related]
30. Humanized anti-DEspR IgG4
Gromisch CM; Tan GLA; Pasion KA; Moran AM; Gromisch MS; Grinstaff MW; Carr FJ; Herrera VLM; Ruiz-Opazo N
BMC Cancer; 2021 Apr; 21(1):407. PubMed ID: 33853558
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy with 5-aminolevulinic acid (ALA) impairs tumor initiating and chemo-resistance property in head and neck cancer-derived cancer stem cells.
Yu CH; Yu CC
PLoS One; 2014; 9(1):e87129. PubMed ID: 24475244
[TBL] [Abstract][Full Text] [Related]
32. A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
Rajeshkumar NV; Rasheed ZA; García-García E; López-Ríos F; Fujiwara K; Matsui WH; Hidalgo M
Mol Cancer Ther; 2010 Sep; 9(9):2582-92. PubMed ID: 20660600
[TBL] [Abstract][Full Text] [Related]
33. Cancer Stem Cells-Origins and Biomarkers: Perspectives for Targeted Personalized Therapies.
Walcher L; Kistenmacher AK; Suo H; Kitte R; Dluczek S; Strauß A; Blaudszun AR; Yevsa T; Fricke S; Kossatz-Boehlert U
Front Immunol; 2020; 11():1280. PubMed ID: 32849491
[TBL] [Abstract][Full Text] [Related]
34. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy.
Das PK; Zahan T; Abdur Rakib M; Khanam JA; Pillai S; Islam F
Anticancer Agents Med Chem; 2019; 19(15):1796-1808. PubMed ID: 31272363
[TBL] [Abstract][Full Text] [Related]
35. Cancer stem cells--important players in tumor therapy resistance.
Colak S; Medema JP
FEBS J; 2014 Nov; 281(21):4779-91. PubMed ID: 25158828
[TBL] [Abstract][Full Text] [Related]
36. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
[TBL] [Abstract][Full Text] [Related]
37. Targeting Cancer Stem Cells Pathways for the Effective Treatment of Cancer.
Dwivedi AR; Thakur A; Kumar V; Skvortsova I; Kumar V
Curr Drug Targets; 2020; 21(3):258-278. PubMed ID: 31433755
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
Oh J; Hlatky L; Jeong YS; Kim D
Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
[TBL] [Abstract][Full Text] [Related]
39. EpCAM-Antibody-Labeled Noncytotoxic Polymer Vesicles for Cancer Stem Cells-Targeted Delivery of Anticancer Drug and siRNA.
Chen J; Liu Q; Xiao J; Du J
Biomacromolecules; 2015 Jun; 16(6):1695-705. PubMed ID: 25988863
[TBL] [Abstract][Full Text] [Related]
40. Liver cancer stem cell markers: Progression and therapeutic implications.
Sun JH; Luo Q; Liu LL; Song GB
World J Gastroenterol; 2016 Apr; 22(13):3547-57. PubMed ID: 27053846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
